Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-06-13FDA Approved: DORZOLAMIDE AND TIMOLOL — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's dorzolamide hydrochloride and timolol maleate ophthalmic solution as an original application (ANDA 205295…
-
FDA approval · 2019-03-22FDA Approved: BIMATOPROST — Original Application (Fosun Pharma USA Inc.)
The FDA approved the original application for bimatoprost, a generic ophthalmic solution manufactured by Fosun Pharma USA Inc., expanding ac…
-
FDA approval · 2019-03-12FDA Approved: ROCKLATAN — Original Application (Alcon Laboratories, Inc.)
The FDA approved ROCKLATAN as an original application for a fixed-dose combination ophthalmic solution of netarsudil 0.02% and latanoprost 0…
-
FDA approval · 2019-03-11FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic Brimonidine tartrate ophthalmic product (Original Application) from Somerset Therapeutics, LLC to treat open-angle gl…
-
FDA approval · 2019-01-24FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Leading Pharma, LLC)
FDA approves the original application for dorzolamide hydrochloride as a generic ophthalmic medication indicated for open-angle glaucoma and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-11-20FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for bimatoprost from Apotex Corp.
-
FDA approval · 2018-10-18FDA Approved: ACETAZOLAMIDE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s Original Application for acetazolamide, confirming a generic version of the drug. The approval allows …
-
FDA approval · 2018-09-12FDA Approved: XELPROS — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves XELPROS (latanoprost) from Sun Pharmaceutical as a new ophthalmic solution for lowering intraocular pressure in open-angle glau…
-
FDA approval · 2018-07-16FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated, authorizing changes to the pr…
-
FDA approval · 2018-06-11FDA Approved: VYZULTA — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for VYZULTA (latanoprostene bunod) submitted by Bausch & Lomb Incorporated.
-
FDA approval · 2017-12-18FDA Approved: RHOPRESSA — Original Application (Alcon Laboratories, Inc.)
FDA approved Rhopressa (netarsudil) from Alcon as an original NDA, indicated to reduce elevated intraocular pressure in adults with open-ang…
-
FDA approval · 2017-11-02FDA Approved: VYZULTA — Original Application (Bausch & Lomb Incorporated)
FDA approved VYZULTA (latanoprostene bunod), from Bausch & Lomb, as a new treatment for open-angle glaucoma and ocular hypertension.
-
FDA approval · 2017-07-07FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's travoprost ophthalmic solution 0.004% through an original application for lowering intraocular pressure in open-angle g…
-
FDA approval · 2017-02-01FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride), a beta-blocker ophthalmic solution. The product is manufac…
-
FDA approval · 2016-08-09FDA Approved: TIMOPTIC — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Timoptic (timolol maleate) from Bausch & Lomb, authorizing updates to the product via an NDA sup…
-
FDA approval · 2016-08-05FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for betaxolol hydrochloride by Sandoz Inc, updating its labeling/approval for use in open-angle glau…
-
FDA approval · 2016-05-05FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate), approving changes to the product labeling requested by Allerg…
-
FDA approval · 2016-04-22FDA Approved: LATANOPROST — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved a generic latanoprost product from Rising Pharma Holdings, Inc. via an Original Application (ANDA 202442) to reduce intraoc…
-
FDA approval · 2016-04-19FDA Approved: BIMATOPROST — Original Application (Sandoz Inc)
FDA approved the original ANDA for bimatoprost ophthalmic solution by Sandoz, establishing a generic version of this glaucoma medication.
-
FDA approval · 2015-12-09FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for latanoprost filed by Bausch & Lomb Incorporated.
-
FDA approval · 2015-11-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
The FDA approved Advagen Pharma Ltd.'s supplemental application for dorzolamide hydrochloride, authorizing a generic version of the drug.
-
FDA approval · 2015-11-10FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc.
-
FDA approval · 2015-11-05FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc.
-
FDA approval · 2015-09-04FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)
FDA notes a supplemental application for Tafluprost Ophthalmic (TAFLUPROST) submitted by Prasco Laboratories. The document indicates the sta…
-
FDA approval · 2015-07-31FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) submitted by Thea Pharma Inc. The product…